Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pursuant to section 29 of the Danish Securities Trading Act, Zealand Pharma A/S (NASDAQ OMX: ZEAL.CO), hereby makes public, that the company has been informed that Idinvest Partners, 117 avenue des Champs-Élysées, 75008 Paris, France, now holds less than 5% of the share capital and the voting rights in Zealand Pharma A/S.
Help employers find you! Check out all the jobs and post your resume.
